COLLEGIUM PHARMACEUTICAL, INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $780.6M | $631.4M | $566.8M | $463.9M | $276.9M |
| Gross profit | $463.3M | $377.3M | $326.2M | $209.5M | $150.6M |
| Operating income | $179.6M | $169.9M | $167.0M | $33.3M | $17.6M |
| Operating expenses | $283.6M | $207.4M | $159.2M | $176.2M | $133.0M |
| Cost of revenue | $317.3M | $254.1M | $240.6M | $254.4M | $126.3M |
| Cash from operations | $329.3M | $205.0M | $274.7M | $124.2M | $103.6M |
| Capital expenditure | $1.7M | $1.7M | $461,000 | $1.6M | $1.9M |
| Free cash flow | $327.6M | $203.3M | $274.3M | $122.6M | $101.6M |
| Share repurchases | $25.1M | $60.0M | $75.0M | $14.1M | $47.9M |
| Total assets | $1.7B | $1.7B | $1.1B | $1.2B | $692.1M |
| Total liabilities | $1.4B | $1.4B | $947.9M | $979.3M | $489.1M |
Shares outstanding 32.4M · Free float 72.2%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.